Kimball Electronics Q1 adjusted profit misses estimates; sales slightly beat on medical growth

By Reuters News


Overview

  • US electronics manufacturer Q1 sales rose 7% yr/yr, slightly beating analyst expectations

  • Adjusted EPS for Q1 missed analyst expectations

  • Company reiterated fiscal 2027 guidance, expecting sales at high end of range


Outlook

  • Kimball Electronics expects fiscal 2027 sales at high end of $1.535-$1.56 bln range

  • Company sees fiscal 2027 adjusted operating margin at 4.4%-4.7%

  • Kimball Electronics expects fiscal 2027 capital expenditures of $50-$60 mln


Result Drivers

  • MEDICAL SEGMENT GROWTH - Co said medical sales rose 14% yr/yr, with 9% organic growth

  • ACQUISITION IMPACT - Helvoet Polymer Technologies contributed $12.4 mln in Q1 sales

  • BROAD-BASED GROWTH - Co said all verticals contributed to organic sales growth


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Slight Beat*

$390.80 mln

$389.85 mln (4 Analysts)

Q1 Adjusted EPS

Miss

$0.25

$0.40 (3 Analysts)

Q1 EPS

$0.11

Q1 Adjusted Net Income

Miss

$6.12 mln

$10.80 mln (3 Analysts)

Q1 Net Income

$2.64 mln

Q1 Adjusted Operating Income

Miss

$16.99 mln

$17.37 mln (2 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Reuters Recommended Reads

  • Nov 2 - Thailand's Fabrinet Q1 revenue jumps 51%, beats estimates on strong broad-based demand

  • Nov 4 - GlobalFoundries Q3 revenue slightly beats, adjusted profit exceeds estimates

  • Nov 4 - CDW Q3 sales beat estimates on financial services segment


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.